[Changes in serum lipids during drug therapy of hypertension].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D008055:Lipids / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D011224:Prazosin / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000097:blood; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D004232:Diuretics; D008055:Lipids; D008075:Lipoproteins, HDL; D014280:Triglycerides; D014665:Vasodilator Agents; D014527:Uric Acid; D013006:Growth Hormone; D011433:Propranolol; D011224:Prazosin
Veränderungen der Serum-Lipide bei der medikamentösen Hochdrucktherapie.